Lee, Tara T. M.
Collett, Corinne
Man, Mei-See
Hammond, Matt
Shepstone, Lee
Hartnell, Sara
Gurnell, Eleanor
Byrne, Caroline
Scott, Eleanor M.
Lindsay, Robert S.
Morris, Damian
Brackenridge, Anna
Dover, Anna R.
Reynolds, Rebecca M.
Hunt, Katharine F.
McCance, David R.
Barnard-Kelly, Katharine
Rankin, David
Lawton, Julia
Bocchino, Laura E.
Sibayan, Judy
Kollman, Craig
Wilinska, Malgorzata E.
Hovorka, Roman
Murphy, Helen R. http://orcid.org/0000-0002-5489-0614
Hunt, Katharine
Rogers, Helen
Morris, Damian
Fowler, Duncan
Rosier, Josephine
Banu, Zeenat
Barker, Sarah
Rayman, Gerry
Gurnell, Eleanor
Byrne, Caroline
Lake, Andrea
Davenport, Katy
Grisoni, Jeannie
Savine, Shannon
Murphy, Helen
Lee, Tara
Wallace, Tara
McKelvey, Alastair
Turner, Elizabeth
Willer, Nina
Collett, Corinne
Man, Mei-See
Flanagan, Emma
Hammond, Matt
Shepstone, Lee
Brackenridge, Anna
White, Sara
Reid, Anna
Okolo, Olanike
Scott, Eleanor
Endersby, Del
Dover, Anna
Dougherty, Frances
Johnston, Susan
Reynolds, Rebecca
Lindsay, Robert
Carty, David
Mackin, Sharon
Crawford, Isobel
Buchan, Ross
McCance, David
Jones, Louisa
Quinn, Joanne
Cains, Sarah
Ayman, Goher
,
Funding for this research was provided by:
Efficacy and Mechanism Evaluation Programme (NIHR EME reference 16/35/01)
Diabetes Research and Wellness Foundation (SECF/21)
Juvenile Diabetes Research Foundation International (#22-2013-266 and #2-RSC-2019-828-M-N)
Article History
Received: 23 February 2022
Accepted: 4 March 2022
First Online: 5 April 2022
Declarations
:
: This clinical study protocol was given favourable opinion by the East of England (Cambridge Central Research Ethics Committee reference 18/EE/0084) and approved by the Health Regulation Authority (HRA) for participating NHS organisations in England and by NHS organisations in Scotland and Northern Ireland. Each participant signed a consent form prior to participating in the study. A notification of no objection was provided by the Medicines and Healthcare Products Regulatory Agency (MHRA) prior to CE marking of the CamAPS FX and Dexcom G6 CGM.
: Not applicable.
: HRM sits on the Medtronic European Scientific Advisory Board and reports speaker honoraria from Dexcom, Abbott, Medtronic and Novo Nordisk. EMS reports receiving speaker honoraria from Abbott Diabetes Care and Eli-Lilly. RH reports receiving speaker honoraria from Eli Lilly, Dexcom and Novo Nordisk, receiving license and/or consultancy fees from B. Braun and Abbott Diabetes Care; patents related to closed-loop, and being director at CamDiab. MEW reports patents related to closed-loop and being a consultant at CamDiab. SH is a UK member of the Medtronic Advisory Board and reports being a consultant at CamDiab and providing training for Dexcom. Dexcom are supplying CGM systems at reduced cost.